Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 6

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

NETWORK 4OTHER 1NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 23Breast 6Sarcoma 1Other solid neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 6Sleep Wake Disorders 1Fatigue 1

Interventions

Cyclophosphamide 171Docetaxel 164Paclitaxel 160Trastuzumab 152Capecitabine 130Tamoxifen 119Letrozole 105Epirubicin 93Doxorubicin 83Anastrozole 83exemestane 77Fulvestrant 75Carboplatin 64Fluorouracil 63Radiotherapy 61pertuzumab 59Gemcitabine 55Vinorelbine 43Goserelin 39eribulin 36130-nm albumin-bound paclitaxel 36palbociclib 32Bevacizumab 32ribociclib 30Zoledronic Acid 29Lapatinib 29Methotrexate 28Drug Therapy 28Chemotherapy, Adjuvant 28Ado-Trastuzumab Emtansine 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Triptorelin Pamoate × Breast × Clear all
NCT00066690 2026-02-06

SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed
3,066 enrolled 15 charts
Breast

Breast Neoplasms

NCT00066703 2026-02-06

TEXT

ETOP IBCSG Partners Foundation

Phase 3 Completed
2,672 enrolled 14 charts
Breast

Breast Neoplasms

NCT00412022 2023-03-24

HOBOE

National Cancer Institute, Naples

Phase 3 Unknown
1,294 enrolled
Breast

Breast Neoplasms

NCT00066807 2016-10-28

PERCHE

ETOP IBCSG Partners Foundation

Phase 3 Terminated
29 enrolled 6 charts
Breast

Breast Neoplasms

NCT00659373 2016-07-25

Co-SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed
86 enrolled 4 charts
Breast

Breast Neoplasms, Fatigue, Sleep Wake Disorders

NCT00311636 2013-06-26

Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

National Cancer Institute (NCI)

Phase 3 Completed
280 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡